Fintel on MSN8h
BMO Capital Initiates Coverage of Avidity Biosciences (RNA) with Outperform Recommendation
Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Outperform ...
Avidity Biosciences initiated with an Outperform at BMO Capital
BMO Capital initiated coverage of Avidity Biosciences (RNA) with an Outperform rating and $72 price target Avidity’s pipeline includes ...
Dyne Therapeutics' $4.3 Billion Peak Sales Potential? Analyst Highlights Key Strengths And Risks
BMO Capital Markets initiated coverage on Dyne Therapeutics, Inc. (NASDAQ:DYN), focused on developing therapies for ...
Dyne wins new Outperform at BMO on prospects for lead drug
Dyne Therapeutics (NASDAQ:DYN) traded higher in the premarket on Wednesday after BMO Capital Markets launched its coverage with an Outperform recommendation and a $50 per share target, citing the ...
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
B. Riley Securities analyst Yuan Zhi initiated coverage on Radiopharm Theranostics Limited RADX with a Buy rating and ...
Yahoo Finance23h
Precision BioSciences, Inc. (DTIL)
After hours: March 11 at 5:39:39 PM EDT Loading Chart for DTIL ...